2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2

Why choose Biosearch Technologies’ to supply your SARS-CoV-2 kit?

• Each lot of the probe and primer set is released for distribution by CDC testing results
• Product in stock ships same or next business day
• From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in US CDC protocols
• Proven track record supporting public health crises with the expertise to rapidly scale up
• Now the only approved commercial supplier of the 2019-nCoV CDC-qualified Probe and Primer Kit labeled with BHQ™ dye

The following CDC-qualified lots of 2019-nCoV CDC Probe and Primer Kits are available: 143503, 143764, 144000, 144604

order now in the
new transaction portal

• Product insert
• Certificate of Analysis, Lot #143503
• Certificate of Analysis, Lot #143764
• Certificate of Analysis, Lot #144000
• Certificate of Analysis, Lot #144604
• CDC - 2019-nCoV Real-Time RT-PCR Diagnostic Panel - Fact Sheet for Healthcare Providers
• CDC - 2019-nCoV Real-Time RT-PCR Diagnostic Panel - Fact Sheet for Patients
• SDS for unlabeled oligos
• SDS for fluorescently-labeled oligos

Do you have any questions?

For a complete SARS-CoV-2 Quality Solution, consider the AccuPlex™ SARS-CoV-2 Verification Panel coupled with the AccuPlex™ SARS-CoV-2 Reference Material Kit from LGC SeraCare Life Sciences. The target sequence of interest is packaged into a stable non-infectious, and replication-deficient alphavirus particle and the products contain positive materials directed against the published CDC and WHO consensus sequences and the S gene. Also includes negative materials targeting the human RNase P gene.